Penumbra, Inc Interest Expense Nonoperating
Penumbra, Inc (PEN) reported Interest Expense Nonoperating of $311.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-07-30
- Penumbra, Inc interest expense nonoperating for the quarter ending 2026-06-30 was $311.00K, a 2.51% decline year-over-year.
- Penumbra, Inc interest expense nonoperating for the quarter ending 2026-03-31 was $317.00K, a 1.55% decline year-over-year.
- Penumbra, Inc interest expense nonoperating for the quarter ending 2025-12-31 was $333.00K, a 1.19% decline year-over-year.
- Penumbra, Inc interest expense nonoperating for the quarter ending 2025-09-30 was $338.00K, a 0.60% increase year-over-year.
- Penumbra, Inc interest expense nonoperating for fiscal 2025 was $1.31M, a 7.55% decline from fiscal 2024.
- Penumbra, Inc interest expense nonoperating for fiscal 2024 was $1.42M, a 18.46% decline from fiscal 2023.
- Penumbra, Inc interest expense nonoperating for fiscal 2023 was $1.74M, a 0.57% decline from fiscal 2022.
- Penumbra, Inc interest expense nonoperating for fiscal 2022 was $1.75M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $311.00K 10-Q · filed 2026-07-30 | $628.00K 10-Q · filed 2026-07-30 | $961.00K derived: sum of 3 quarters · filed 2026-07-30 | $1.30M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $317.00K 10-Q · filed 2026-05-06 | $650.00K derived: sum of 2 quarters · filed 2026-05-06 | $988.00K derived: sum of 3 quarters · filed 2026-05-06 | $1.31M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $333.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $671.00K derived: sum of 2 quarters · filed 2026-02-25 | $990.00K derived: sum of 3 quarters · filed 2026-07-30 | $1.31M 10-K · filed 2026-02-25 |
| 2025-09-30 | $338.00K 10-Q · filed 2025-11-05 | $657.00K derived: sum of 2 quarters · filed 2026-07-30 | $978.00K 10-Q · filed 2025-11-05 | $1.32M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $319.00K 10-Q · filed 2026-07-30 | $640.00K 10-Q · filed 2026-07-30 | $978.00K derived: sum of 3 quarters · filed 2026-07-30 | $1.31M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $322.00K 10-Q · filed 2026-05-06 | $659.00K derived: sum of 2 quarters · filed 2026-05-06 | $995.00K derived: sum of 3 quarters · filed 2026-05-06 | $1.34M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $337.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $673.00K derived: sum of 2 quarters · filed 2026-02-25 | $1.02M derived: sum of 3 quarters · filed 2026-02-25 | $1.42M 10-K · filed 2026-02-25 |
| 2024-09-30 | $336.00K 10-Q · filed 2025-11-05 | $680.00K derived: sum of 2 quarters · filed 2025-11-05 | $1.08M 10-Q · filed 2025-11-05 | $1.52M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $344.00K 10-Q · filed 2025-07-29 | $746.00K 10-Q · filed 2025-07-29 | $1.18M derived: sum of 3 quarters · filed 2026-02-25 | $1.62M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $402.00K 10-Q · filed 2025-04-23 | $838.00K derived: sum of 2 quarters · filed 2026-02-25 | $1.28M derived: sum of 3 quarters · filed 2026-02-25 | |
| 2023-12-31 | $436.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $878.00K derived: sum of 2 quarters · filed 2026-02-25 | $1.74M 10-K · filed 2026-02-25 | |
| 2023-09-30 | $442.00K 10-Q · filed 2024-10-30 | $1.30M 10-Q · filed 2024-10-30 | ||
| 2022-12-31 | $1.75M 10-K · filed 2025-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |